글로벌 Cataplexy 치료 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 Cataplexy 치료 시장

글로벌 졸음증 치료 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에 언급된 예측 기간 동안 시장이 7.10%의 CAGR로 성장할 것으로 분석합니다.

기면증은 근육의 긴장도와 조절력을 갑작스럽고 일시적으로 상실하는 신경계 질환입니다. 기면증 발작은 불안, 스트레스, 기쁨, 분노, 두려움, 웃음 또는 우울한 기분과 같은 강하고 극단적인 감정으로 인해 유발됩니다. 뇌 조직에서 히포크레틴이 고갈되는 것과 관련이 있습니다. 기면증 의 증상 이며 눈꺼풀 처짐, 턱 떨림, 얼굴 경련, 깜빡임, 언어 장애 및 무릎 떨림이 특징입니다.

희귀 질환의 유병률 증가, 기면증과 같은 신경 질환, 건강에 해로운 생활 방식, 스트레스 수치의 급증, 의료비 지출 증가, 질병에 대한 인식을 확대하기 위한 정부 이니셔티브 확대는 글로벌 기면증 치료 시장을 확대할 요인입니다.

증가하는 R&D 활동, 첨단 치료법에 대한 수요 증가, 주요 제약 회사의 새로운 치료법에 대한 집중 등으로 인해 2021~2028년 예측 기간 동안 글로벌 기면증 치료 시장에 유익한 기회가 제공될 것입니다.

기면증을 치료할 수 있는 방법은 없으며, 증상만 관리하는 것이 치료법입니다. 환자와 의료 서비스 제공자가 이 질병에 대해 인식이 부족한 것이 시장 성장을 방해하는 요인이며, 위에서 언급한 예측 기간 동안 글로벌 기면증 치료 시장에 더욱 어려움을 겪을 것입니다.

This cataplexy treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global cataplexy treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Cataplexy Treatment Market Scope and Market Size

The cataplexy treatment market is segmented on the basis of treatment, dosage, route of administration, diagnosis, symptoms, end-users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the cataplexy treatment market is segmented into sodium oxybate, tricyclic antidepressant, amphetamines, selective serotonin uptake reinhibitors (SSRIs), and modafinil. Tricyclic antidepressant has been further sub-segmented into clomipramine, imipramine, and desipramine. Selective serotonin uptake reinhibitors (SSRIs) have been further sub- segmented into fluoxetine and venlafaxine.
• On the basis of dosage, the cataplexy treatment market is segmented into tablet, solution, capsule, and others.
• On the basis of route of administration, the cataplexy treatment market is segmented into oral and others.
• On the basis of diagnosis, the cataplexy treatment market is segmented into physical evaluation, written evaluation, polysomnogram, and multiple sleep latency test (MSLT).
• On the basis of symptoms, the cataplexy treatment market is segmented into drooping eyelids, jaw tremor, facial twitching, flickering, speech difficulty and others.
• On the basis of end-users, the cataplexy treatment market is segmented into clinic, hospital, and others.
• The cataplexy treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Global Cataplexy Treatment Market Country Level Analysis

Global cataplexy treatment market is analyzed and market size information is provided by the country, treatment, dosage, route of administration, diagnosis, symptoms, end-users and distribution channel as referenced above.

The countries covered in the global cataplexy treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the cataplexy treatment market due to the presence of major key players, continuous technological development, well-developed healthcare sector, increasing prevalence of disease, and increasing awareness towards health in this region. Global cataplexy treatment market in the Asia-Pacific and Europe is expected to grow during the forecast period due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Global cataplexy treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Cataplexy Treatment Market Share Analysis

Global cataplexy treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global cataplexy treatment market.

글로벌 카탈플렉스 치료 시장 보고서에 포함된 주요 기업으로는 Allergan, AstraZeneca, Lilly, GlaxoSmithKline plc, Johnson & Johnson Private Limited, Pfizer Inc., Merck Sharp & Dohme Corp., Sanofi, Sun Pharmaceutical Industries Ltd., Hisamitsu Pharmaceutical Co. Inc., Purdue Pharma LP, H. Lundbeck A/S, Jazz Pharmaceuticals, Inc., Hikma Pharmaceuticals PLC, Mylan NV, Teva Pharmaceutical Industries Ltd. 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-64050